Direct Oral Anticoagulants in Primary and Secondary Prevention of Thrombotic Events: 2026 ACC Scientific Statement
JACC · 2026-09 · 88 (11) · 1255-1283
DOI: 10.1016/j.jacc.2026.05.033 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift JACC, 2026-09. Verfasst von Dharam J Kumbhani und 7 weiteren Autor:innen. Hauptthemen laut MEDLINE: Secondary Prevention, Primary Prevention, Cardiology, Thrombosis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 242 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Zitieren
APA
Kumbhani, D. J., Armbruster, A. L., Cheng, R. K., Chrispin, J., Fischer, U., Holbrook, A. M., Joglar, J., & Sevestre, M. A. (2026). Direct Oral Anticoagulants in Primary and Secondary Prevention of Thrombotic Events: 2026 ACC Scientific Statement. JACC, 88(11), 1255-1283. https://doi.org/10.1016/j.jacc.2026.05.033
Vancouver
Kumbhani DJ, Armbruster AL, Cheng RK, Chrispin J, Fischer U, Holbrook AM, et al. Direct Oral Anticoagulants in Primary and Secondary Prevention of Thrombotic Events: 2026 ACC Scientific Statement. JACC. 2026;88(11):1255-1283. doi:10.1016/j.jacc.2026.05.033
BibTeX
@article{Kumbhani2026,
author = {Kumbhani, Dharam J and Armbruster, Anastasia L and Cheng, Richard K and Chrispin, Jonathan and Fischer, Urs and Holbrook, Anne Marie and Joglar, Jose and Sevestre, Marie-Antoinette},
title = {Direct Oral Anticoagulants in Primary and Secondary Prevention of Thrombotic Events: 2026 ACC Scientific Statement},
journal = {JACC},
year = {2026},
volume = {88},
number = {11},
pages = {1255--1283},
doi = {10.1016/j.jacc.2026.05.033}
}
EUVIMED